$AWR

This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.

American States Water (AWR) raised its dividend by 8.2%, extending its streak to 72 years. The company, with 1 million customers, operates water and electric utilities in California and maintains facilities at military bases. It plans to invest $185M-$220M this year and recently acquired a water system for $5.3M. AWR has grown its dividend at an 8.7% annual rate over the past decade, with a current yield of 2.5%.

Original reporting
Published Aug 23, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 23, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It. — source image
Decision brief

The 30-second read

$AWRBullishMed
01

Why it matters

The dividend hike reinforces AWR's appeal to income investors and may trigger modest buying pressure, though the impact is likely limited to the dividend‑focused segment.

02

Market read

AWR's dividend increase underscores the strength of dividend‑paying utilities and could spur modest inflows into similar high‑yield stocks.

03

What to watch

Potential rate‑increase pressures and capital‑intensive projects could constrain future cash flow.

Relevance 6/10Novelty 6/10Timing: recent dividend increase

Background

American States Water (AWR) is a regulated water and electric utility with a 72‑year dividend streak, recently raising its payout by 8.2%.

Company-level read

Ticker impact

$AWRBullishMedium confidence
Context

American States Water raised its dividend 8.2% last month, extending its 72‑year dividend growth streak.

Expected impact

Modest upside as dividend‑seeking buyers add to the stock, likely 2‑4% over the next few weeks.

Evidence & confidence

Dividend hikes in utility stocks historically lead to short‑term price support, especially with a long‑standing track record.

Market effects

Highlights the resilience of regulated utility sector and may boost sentiment toward other Dividend Kings.

Positive for U.S. utility stocks, especially those with strong dividend histories.

Limited; primarily a U.S. income‑investor story.

Counterpoint

The modest dividend bump may be priced in already, limiting upside.

Key entities

  • American States Water

    U.S. regulated water and electric utility (ticker AWR).

Related articles

$WTRGMedAI 8/10

Filing of Joint Petition for Non-Unanimous Settlement in Pennsylvania Public Utility Commission Proceeding with respect to Proposed Merger with Essential…

Essential Utilities, Inc. (WTRG) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. Filing of Joint Petition for Non-Unanimous Settlement in Pennsylvania Public Utility Commission (the “PaPUC”) Proceeding with respect to Proposed Merger with Essential Utilities, Inc. As previously disclosed, on October 26, 2025, American Water Works Comp

$AWRMed

American States Water Company Announces Second Quarter 2026 Results

AMERICAN STATES WATER CO (AWR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 American States Water Company Announces Second Quarter 2026 Results • A 25.3% increase, or $0.22 per share, in reported second quarter 2026 consolidated diluted EPS compared to second quarter of 2025 ◦ Increased earnings per share at all operating business segments •

$XFORMedAI 8/10

X4 Pharmaceuticals Secures Up to $150 Million in New Debt Financing From K2 HealthVentures

X4 Pharmaceuticals (XFOR) secured up to $150M in debt financing from K2 HealthVentures, refinancing existing debt and providing additional capital. The initial $80M tranche was used to repay $75M in outstanding debt. The new agreement offers extended repayment terms and supports clinical development, including the potential commercial launch of mavorixafor for chronic neutropenia.

$AVOMed

Mission Produce unveils five-year targets, $100M buyback, aims to double sales and triple EBITDA by 2035

Mission Produce announced a five-year plan with mid-single-digit organic sales growth, 300bps margin expansion, and 2035 targets to double sales to $4B and triple Adjusted EBITDA to $450M. The company reaffirmed fiscal 2H26 Adjusted EBITDA outlook of $84–88M and Q426 Adjusted EBITDA of $52–55M. It also launched a $100M share repurchase program, with 290,994 shares repurchased at an average price of $12.94.